RESUMO
Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. High levels of plasma homocysteine (HCY) increase oxidative stress and reduce endothelial-dependent relaxation. We determined whether hyperhomocysteinemia-induced endothelial dysfunction is mediated through inhibition of cellular transport of L-arginine. In endothelial cells, HCY had a biphasic effect on arginine transport. HCY treatment for 6 hr increased L-arginine uptake by 34%; however, uptake was decreased by 25% after 24 h. HCY caused membrane hyperpolarization during both 6 and 24 h incubation periods, indicating that the negative charge facilitating arginine uptake was maintained. HCY significantly reduced expression of cellular arginine transporter protein (CAT-1) after 24 h treatment; whereas endothelial nitric oxide synthase (eNOS) protein levels and basal eNOS activity were not altered. Nevertheless, nitric oxide (NO) formation was significantly decreased. The antioxidant ascorbic acid prevented the effect of HCY on arginine transport. HCY induced formation of the peroxynitrite biomarker nitrotyrosine, which was blocked by supplemental L-arginine. HCY treatment of aortic rings caused decreased vasorelaxation to acetylcholine, which was prevented by supplemental arginine. In conclusion, HCY decreased NO formation and induced endothelial dysfunction without altering protein level or basal activity of eNOS, but through decreases in function and protein expression of the CAT-1 transporter. Reduced arginine supply may lead to eNOS uncoupling and generation of superoxide, contributing to HCY-induced oxidative stress.
Assuntos
Arginina/metabolismo , Células Endoteliais/efeitos dos fármacos , Homocisteína/toxicidade , Acetilcolina/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Transportador 1 de Aminoácidos Catiônicos/análise , Bovinos , Células Cultivadas , Células Endoteliais/fisiologia , Masculino , Potenciais da Membrana/efeitos dos fármacos , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase Tipo III/metabolismo , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio , Tirosina/análogos & derivados , Tirosina/biossíntese , Vasodilatação/efeitos dos fármacosRESUMO
AIMS/HYPOTHESIS: Type 1 diabetes increases the risk of peripheral ischaemia and impairs recovery once ischaemia occurs, probably because the healing process is hampered by diabetes-induced endothelial dysfunction. In normoglycaemic mice subjected to limb ischaemia, blockade of nerve growth factor (NGF) compromises reparative angiogenesis. In the present study, we evaluated if expressional alterations of endogenous NGF system components are associated with diabetes-related impairment in neovascularisation. In addition, we tested whether the correction of NGF liabilities benefits post-ischaemic healing of Type 1 diabetic animals. METHODS: Unilateral hindlimb ischaemia was produced in streptozotocin-induced Type 1 diabetic mice. Purified murine NGF (20 microg daily for 14 days) or PBS were injected into ischaemic adductors. Non-diabetic mice given PBS served as controls. Hindlimb blood flow was analysed sequentially for up to 14 days. At necroscopy, adductors were removed for quantification of microvessel density, endothelial cell apoptosis and NGF receptor expression. NGF content was determined by ELISA three days after ischaemia. In vitro, we tested whether NGF protects endothelial cells from apoptosis induced by high glucose and whether vascular endothelial growth factor-A (VEGF-A) is involved in this beneficial effect. RESULTS: Muscles removed from Type 1 diabetic mice showed reduced NGF content and up-regulation of the NGF p75 receptor. NGF supplementation promoted capillarisation and arteriogenesis, reduced apoptosis, and accelerated blood flow recovery. NGF stimulated VEGF-A production by human endothelial cells incubated in high-glucose medium and conferred resistance against high-glucose-induced apoptosis via a VEGF-A-mediated mechanism. CONCLUSIONS/INTERPRETATION: NGF protects endothelial cells from apoptosis induced by Type 1 diabetes and facilitates reparative neovascularisation. The findings may open up new therapeutic options for the treatment of diabetic complications.
Assuntos
Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/tratamento farmacológico , Membro Posterior/efeitos dos fármacos , Membro Posterior/lesões , Isquemia/complicações , Isquemia/tratamento farmacológico , Fator de Crescimento Neural/uso terapêutico , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Capilares/efeitos dos fármacos , Capilares/patologia , Capilares/fisiopatologia , Sobrevivência Celular , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/fisiopatologia , Diabetes Mellitus Tipo 1/fisiopatologia , Esquema de Medicação , Avaliação Pré-Clínica de Medicamentos/métodos , Endotélio Vascular/lesões , Endotélio Vascular/patologia , Endotélio Vascular/fisiopatologia , Expressão Gênica , Membro Posterior/irrigação sanguínea , Isquemia/fisiopatologia , Masculino , Camundongos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/fisiopatologia , Músculo Esquelético/ultraestrutura , Neovascularização Patológica/genética , Neovascularização Patológica/fisiopatologia , Neovascularização Fisiológica/efeitos dos fármacos , Neovascularização Fisiológica/fisiologia , Fator de Crescimento Neural/antagonistas & inibidores , Fator de Crescimento Neural/genética , Receptor de Fator de Crescimento Neural , Receptores de Fator de Crescimento Neural/antagonistas & inibidores , Receptores de Fator de Crescimento Neural/efeitos dos fármacos , Receptores de Fator de Crescimento Neural/genética , Reperfusão , Vasos Retinianos/fisiologia , Vasos Retinianos/ultraestrutura , Veias Umbilicais/citologia , Veias Umbilicais/efeitos dos fármacos , Veias Umbilicais/fisiologia , Fator A de Crescimento do Endotélio Vascular/metabolismoRESUMO
The goal of this work was to test the role of nitric oxide synthase (NOS) and its substrate L-arginine in development of tolerance to nitroglycerin's (GTN) vasodilator actions. GTN's effects on NOS activity and NO formation were tested in cultured bovine aortic endothelial cells (BAECs). The arginine to citrulline conversion assay showed that GTN stimulated NOS basal activity in BAECs by approximately 40%, comparable with acetylcholine (ACh)-treated controls. Both effects were blocked by L-NMMA. Photometric assays showed that both GTN and ACh-stimulated NO formation. Both effects were potentiated by L-arginine and inhibited by L-NAME. L-NAME inhibited ACh responses approximately 80% compared with approximately 40% for GTN responses. The aortic ring assay showed that 2 h pretreatment with GTN caused substantial tolerance to GTN's vasodilating effects as evidenced by a 38 fold rightward shift of the concentration-relaxation curve. In contrast to D-arginine, addition of L-arginine substantially inhibited this effect, reducing the rightward shift to 4.4 fold of control values. GTN tolerance was associated with a 40% reduction in L-arginine tissue levels. GTN had a biphasic effect on BAEC uptake of L-arginine, stimulating uptake at 5 and 15 min, and suppressing uptake after 1 and 4 h In summary, acute GTN treatment stimulates endothelial NOS activity in producing NO and increases cellular uptake of L-arginine. Prolonged GTN exposure reduces GTN's vasodilator actions, decreases L-arginine tissue levels and depresses BAECs uptake of L-arginine. Supplementation of L-arginine reduces development of GTN tolerance. These data indicate that GTN tolerance depends in part on activation of the NOS pathway.
Assuntos
Arginina/metabolismo , Tolerância a Medicamentos , Nitroglicerina/farmacologia , Vasodilatadores/farmacologia , Animais , Aorta/citologia , Aorta/efeitos dos fármacos , Transporte Biológico , Bovinos , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Ativação Enzimática , Técnicas In Vitro , Masculino , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/metabolismo , Ratos , Ratos Sprague-Dawley , Vasoconstrição/efeitos dos fármacosRESUMO
We have studied the laminar position, morphology, and synaptic relationships of neurons in the cat superior colliculus which project to the interadjacent division of the lateral posterior nucleus (LPi), using the retrograde transport of horseradish peroxidase. The neurons which project to LPi are remarkably varied in depth, size, morphology, and synaptic density and appear to consist of at least four cell types. Labeled cells were found laminae. Forty-seven percent were found in the superficial gray layer (50-550 micrometer), all but a few within its deep subdivision. Forty-seven percent were located in the optic layer (550-1,200 micrometer), the majority of these being within the upper one-half of the layer Seven percent were found in the intermediate and deep gray layers (below 1,200 micrometer). Cell body area varied widely, ranging from 37 to 768 micrometer 2 (mean of 243 micrometer2). Based on cell size, shape, and dendritic field orientation, we identified four distinct cell morphologies which were labeled. Thirty-five percent were stellate, 32% were vertical fusiform 19% were granule, and 12% were horizontal cells. Electron microscope analysis confirmed that neurons projecting to the lateral posterior nucleus are a morphologically diverse group. A sample of 71 labeled cells varied significantly in density of synaptic input as well as in size, shape, depth, dendritic distribution, and cytology.